tiprankstipranks

Sath Shukla Insider Profile

4 Followers
Sath Shukla, EVP & CFO at Alaunos Therapeutics, holds 1.14M shares in Spero Therapeutics (Ticker: SPRO), holds 80.50K shares in Alaunos Therapeutics (Ticker: TCRT). Most recently, Sath Shukla Sold ― shares of Spero Therapeutics on Aug 29, 2024 for an estimated value of 3.72K.
tipranks
Sath Shukla

Sath Shukla
Alaunos Therapeutics (TCRT)
EVP & CFO

Ranked #25,730 out of 99,635 Corporate Insiders

Profitable Transactions

100%
4 out of 4 Profitable Transactions

Average Return

+12.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
87.35%
12.65%
A breakdown of Sath Shukla's holdings

Insider Roles

Spero Therapeutics
(SPRO)
CEO & President
Alaunos Therapeutics
(TCRT)
EVP & CFO
Roles that Sath Shukla holds in companies

Most Profitable Insider Trade

Stock:
Spero Therapeutics
(SPRO)
Rating:Informative Sell
Date:Feb 05, 2024 - Today
Return:+19.40%
The most profitable trade made by Sath Shukla

Sath Shukla's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Alaunos Therapeutics
Jan 31, 2020
EVP & CFO
Uninformative Buy
$189.98K
Spero Therapeutics
Aug 29, 2024
CEO & President
Informative Sell
3.72K
$1.31M
List of latest transactions for each holding click on a transaction to see Sath Shukla's performance on stock

Sath Shukla insider profile FAQ

What is the percentage of profitable transactions made by Sath Shukla?
The percentage of profitable transactions made by Sath Shukla is 100%.
    What is the average return per transaction made by Sath Shukla?
    The average return per transaction made by Sath Shukla is 12.00%.
      What stocks does Sath Shukla hold?
      Sath Shukla holds: TCRT, SPRO stocks.
        What was Sath Shukla’s latest transaction?
        Sath Shukla latest transaction was an Informative Sell of $3.72K.
          What was Sath Shukla's most profitable transaction?
          Sath Shukla’s most profitable transaction was an Informative Sell of SPRO stock on February 5, 2024. The return on the trade was 19.40%.
            What is Sath Shukla's role in Alaunos Therapeutics?
            Sath Shukla's role in Alaunos Therapeutics is EVP & CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.